PortfoliosLab logo

Anebulo Pharmaceuticals, Inc. (ANEB)

Equity · Currency in USD · Last updated Jan 28, 2023

Company Info

ISINUS0345691036
CUSIP034569103
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.66
Year Range$1.79 - $7.70
EMA (50)$2.79
EMA (200)$3.69
Average Volume$7.14K
Market Capitalization$68.19M

ANEBShare Price Chart


Loading data...

ANEBPerformance

The chart shows the growth of $10,000 invested in Anebulo Pharmaceuticals, Inc. in May 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,800 for a total return of roughly -62.00%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2023
-10.14%
-1.16%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANEBCompare to other instruments

Search for stocks, ETFs, and funds to compare with ANEB

Anebulo Pharmaceuticals, Inc.

ANEBReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD9.74%6.02%
1M5.98%6.30%
6M-9.22%-0.05%
1Y-60.59%-6.42%
5Y-42.91%-1.82%
10Y-42.91%-1.82%

ANEBMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20227.48%10.29%-2.88%-47.60%-27.22%92.59%-42.60%16.25%-19.31%-13.93%-8.71%10.18%
202117.14%-16.83%6.42%-7.00%-2.96%1.53%-9.77%2.50%

ANEBSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anebulo Pharmaceuticals, Inc. Sharpe ratio is -0.52. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.20SeptemberOctoberNovemberDecember2023
-0.52
-0.27
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANEBDividend History


Anebulo Pharmaceuticals, Inc. doesn't pay dividends

ANEBDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2023
-70.28%
-15.14%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANEBWorst Drawdowns

The table below shows the maximum drawdowns of the Anebulo Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anebulo Pharmaceuticals, Inc. is 80.00%, recorded on Oct 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80%May 24, 2021358Oct 21, 2022
-1.41%May 10, 20217May 18, 20211May 19, 20218

ANEBVolatility Chart

Current Anebulo Pharmaceuticals, Inc. volatility is 120.20%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2023
120.20%
16.76%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)